Atomoxetine restores the response inhibition network in Parkinson’s disease
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Parkinson's disease impairs the inhibition of responses, and whilst impulsivity is mild for some patients, severe impulse control disorders affect ∼10% of cases. Based on preclinical models we proposed that noradrenergic denervation contributes to the impairment of response inhibition, via changes in the prefrontal cortex and its subcortical connections. Previous work in Parkinson's disease found that the selective noradrenaline reuptake inhibitor atomoxetine could improve response inhibition, gambling decisions and reflection impulsivity. Here we tested the hypotheses that atomoxetine can restore functional brain networks for response inhibition in Parkinson's disease, and that both structural and functional connectivity determine the behavioural effect. In a randomized, double-blind placebo-controlled crossover study, 19 patients with mild-to-moderate idiopathic Parkinson's disease underwent functional magnetic resonance imaging during a stop-signal task, while on their usual dopaminergic therapy. Patients received 40 mg atomoxetine or placebo, orally. This regimen anticipates that noradrenergic therapies for behavioural symptoms would be adjunctive to, not a replacement for, dopaminergic therapy. Twenty matched control participants provided normative data. Arterial spin labelling identified no significant changes in regional perfusion. We assessed functional interactions between key frontal and subcortical brain areas for response inhibition, by comparing 20 dynamic causal models of the response inhibition network, inverted to the functional magnetic resonance imaging data and compared using random effects model selection. We found that the normal interaction between pre-supplementary motor cortex and the inferior frontal gyrus was absent in Parkinson's disease patients on placebo (despite dopaminergic therapy), but this connection was restored by atomoxetine. The behavioural change in response inhibition (improvement indicated by reduced stop-signal reaction time) following atomoxetine correlated with structural connectivity as measured by the fractional anisotropy in the white matter underlying the inferior frontal gyrus. Using multiple regression models, we examined the factors that influenced the individual differences in the response to atomoxetine: the reduction in stop-signal reaction time correlated with structural connectivity and baseline performance, while disease severity and drug plasma level predicted the change in fronto-striatal effective connectivity following atomoxetine. These results suggest that (i) atomoxetine increases sensitivity of the inferior frontal gyrus to afferent inputs from the pre-supplementary motor cortex; (ii) atomoxetine can enhance downstream modulation of frontal-subcortical connections for response inhibition; and (iii) the behavioural consequences of treatment are dependent on fronto-striatal structural connections. The individual differences in behavioural responses to atomoxetine highlight the need for patient stratification in future clinical trials of noradrenergic therapies for Parkinson's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250
Friston, K. J., Harrison, L., & Penny, W. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00202-7 · Cited by 4,583
On the ability to inhibit thought and action: a theory of an act of control
Logan, G. D., & Cowan, W. B. (1984) · Psychological Review · doi:10.1037/0033-295x.91.3.295 · Cited by 2,590
Inhibition and the right inferior frontal cortex: one decade on
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2014) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2013.12.003 · Cited by 2,166
Self-citationStop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771 · cited 2×
“Interactions between the preSMA, inferior frontal gyrus, and their projections to the subthalamic nucleus are critical for response inhibition (Aron et al., 2003; Chambers et al., 2006; Frank et al., 2007; Ballanger et al., 2009; Duann et al., 2009; Forstmann et al., 2012; Rae et al., 2015).”
BackgroundSelf-citationBayesian model selection for group studies
Stephan, K. E., Penny, W. D., Daunizeau, J., Moran, R. J., & Friston, K. J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.03.025 · Cited by 1,423
Functional significance of the cortico-subthalamo-pallidal “hyperdirect” pathway
Nambu, A., Tokuno, H., & Takada, M. (2002) · Neuroscience Research · doi:10.1016/s0168-0102(02)00027-5 · Cited by 1,371
Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease
Redgrave, P., Rodriguez, M., Smith, Y., Rodriguez-Oroz, M. C., Lehericy, S., Bergman, H., Agid, Y., DeLong, M. R., & Obeso, J. A. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2915 · Cited by 1,134 · cited 2×
“The thalamus, striatum, and globus pallidus are also relevant to response inhibition (Nambu et al., 2002; Redgrave et al., 2010; Wiecki and Frank, 2013) and our models implicitly incorporate these subcortical stage posts.”
BackgroundBymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
About “axial” and “radial” diffusivities
Wheeler‐Kingshott, C. A. M., & Cercignani, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21965 · Cited by 885 · cited 1×
“This may relate to loss of axonal projections through secondary degeneration, changes in myelin, or reduced axonal calibre (Wheeler-Kingshott and Cercignani, 2009; Rae et al., 2012).”
BackgroundTen simple rules for dynamic causal modeling
Stephan, K. E., Penny, W. D., Moran, R. J., den Ouden, H. E. M., Daunizeau, J., & Friston, K. J. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.11.015 · Cited by 803 · cited 4×
“For each model, the free energy estimate of the logevidence (F) provides a measure of model accuracy adjusted for complexity (Stephan et al., 2010).”
BackgroundMethodInfluentialComparing families of dynamic causal models
Penny, W. D., Stephan, K. E., Daunizeau, J., Rosa, M. J., Friston, K. J., Schofield, T. M., & Leff, A. P. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000709 · Cited by 688 · cited 2×
“When the exceedance probability does not exceed 0.9, it is recommended to average all models with a probability of 40.05 (Penny et al., 2010).”
BackgroundMethodInfluentialEagle, D. M., Bari, A., & Robbins, T. W. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1127-6 · Cited by 548 · cited 2×
“, 2015) at the expense of understanding the individual contribution of each monoamine and links to preclinical models (Eagle et al., 2008; Bari et al., 2011).”
BackgroundSelf-citationExecutive “Brake Failure” following Deactivation of Human Frontal Lobe
Chambers, C. D., Bellgrove, M. A., Stokes, M. G., Henderson, T. R., Garavan, H., Robertson, I. H., Morris, A. P., & Mattingley, J. B. (2006) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2006.18.3.444 · Cited by 544 · cited 6×
“We selected these regions given their essential contributions to action stopping (Chambers et al., 2006; Aron et al., 2014; Rae et al., 2015), and their dysfunction during action control in Parkinson’s disease (Rowe et al.”
BackgroundMethodInfluentialIdentifying neural drivers with functional MRI: an electrophysiological validation
David, O., Guillemain, I., Saillet, S., Reyt, S., Deransart, C., Segebarth, C., & Depaulis, A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060315 · Cited by 533 · cited 1×
“Although DCM has been validated using functional MRI combined with invasive recordings in animals (David et al., 2008), it is also useful to seek corroboration from other methods.”
MethodNonlinear dynamic causal models for fMRI
Stephan, K. E., Kasper, L., Harrison, L. M., Daunizeau, J., den Ouden, H. E. M., Breakspear, M., & Friston, K. J. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.04.262 · Cited by 416
Broca's Region: Novel Organizational Principles and Multiple Receptor Mapping
Amunts, K., Lenzen, M., Friederici, A. D., Schleicher, A., Morosan, P., Palomero-Gallagher, N., & Zilles, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000489 · Cited by 357
Free Energy, Precision and Learning: The Role of Cholinergic Neuromodulation
Moran, R. J., Campo, P., Symmonds, M., Stephan, K. E., Dolan, R. J., & Friston, K. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4255-12.2013 · Cited by 312
Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder
Chamberlain, S. R., del Campo, N., Dowson, J., Müller, U., Clark, L., Robbins, T. W., & Sahakian, B. J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.003 · Cited by 288 · cited 4×
“Individual differences in Parkinson’s disease severity, drug levels, and white matter structure of frontal-subcortical tracts influence cognitive and behavioural dysfunction including response inhibition (Chamberlain et al., 2007; Ye et al., 2015).”
BackgroundInfluentialSelf-citationPrefrontal and monoaminergic contributions to stop-signal task performance in rats
Bari, A., Mar, A. C., Theobald, D. E., Elands, S. A., Oganya, K. C. N. A., Eagle, D. M., & Robbins, T. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1543-11.2011 · Cited by 188
Self-citationSelection and stopping in voluntary action: A meta-analysis and combined fMRI study
Rae, C. L., Hughes, L. E., Weaver, C., Anderson, M. C., & Rowe, J. B. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.10.012 · Cited by 140 · cited 1×
“The right inferior frontal gyrus peak was used due to right hemisphere lateralization in response inhibition tasks (Aron et al., 2014; Rae et al., 2014), and greater right inferior frontal gyrus activation during stopping at the second-level in both patients and controls.”
MethodSelf-citationBari, A., & Robbins, T. W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3141-6 · Cited by 105 · cited 2×
“Although we emphasize the role of noradrenaline in response inhibition (Eagle and Baunez, 2010; Bari and Robbins, 2013), dopamine also influences impulsivity and the control of action (Hughes et al., 2010, 2013; Cummins et al., 2012; Nandam et al., 2013; Cubillo et al., 2014; Napier et al., 2014).”
BackgroundSelf-citationDopamine transporter genotype predicts behavioural and neural measures of response inhibition
Cummins, T. D. R., Hawi, Z., Hocking, J., Strudwick, M., Hester, R., Garavan, H., Wagner, J., Chambers, C. D., & Bellgrove, M. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.104 · Cited by 74 · cited 3×
“Although we emphasize the role of noradrenaline in response inhibition (Eagle and Baunez, 2010; Bari and Robbins, 2013), dopamine also influences impulsivity and the control of action (Hughes et al., 2010, 2013; Cummins et al., 2012; Nandam et al., 2013; Cubillo et al., 2014; Napier et al., 2014).”
BackgroundDopamine D2 Receptor Modulation of Human Response Inhibition and Error Awareness
Nandam, L. S., Hester, R., Wagner, J., Dean, A. J., Messer, C., Honeysett, A., Nathan, P. J., & Bellgrove, M. A. (2013) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00327 · Cited by 50 · cited 1×
“Although we emphasize the role of noradrenaline in response inhibition (Eagle and Baunez, 2010; Bari and Robbins, 2013), dopamine also influences impulsivity and the control of action (Hughes et al., 2010, 2013; Cummins et al., 2012; Nandam et al., 2013; Cubillo et al., 2014; Napier et al., 2014).”
Background
Cited by
Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia
Hughes, L. E., Rittman, T., Robbins, T. W., & Rowe, J. B. (2018) · Brain · doi:10.1093/brain/awy176 · Cited by 81
“Whilst we explicitly examined the modelled interactions between three frontal cortical regions and suggest explanations of beta desynchronization based on cortical network dynamics, we acknowledge that additional regions have been associated with response inhibition (Ye et al., 2014; Rae et al., 2016) but deeper sourc…”
BackgroundSelf-citationAtomoxetine and citalopram alter brain network organization in Parkinson’s disease
Borchert, R. J., Rittman, T., Rae, C. L., Passamonti, L., Jones, S. P., Vatansever, D., Vázquez Rodríguez, P., Ye, Z., Nombela, C., Hughes, L. E., et al. (2019) · Brain Communications · doi:10.1093/braincomms/fcz013 · Cited by 14
Self-citationTrempler, I., Bürkner, P.-C., El-Sourani, N., Binder, E., Reker, P., Fink, G. R., & Schubotz, R. I. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.116674 · Cited by 6
Evidence and implications of abnormal predictive coding in dementia
Kocagoncu, E., Klimovich-Gray, A., Hughes, L. E., & Rowe, J. B. (2021) · Brain · doi:10.1093/brain/awab254 · Cited by 3
Self-citation
Metadata
- Authors
- Rae, C. L., Nombela, C., Rodríguez, P. V., Ye, Z., Hughes, L. E., Jones, P. S., Ham, T., Rittman, T., Coyle-Gilchrist, I., Regenthal, R., Sahakian, B. J., Barker, R. A., Robbins, T. W., & Rowe, J. B.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06-24
- Volume
- 139
- Issue
- 8
- Pages
- 2235-2248
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2396513098
- Cited by
- 95
- References
- 25
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.